Compare BX & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BX | TMO |
|---|---|---|
| Founded | 1985 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0B | 164.3B |
| IPO Year | 2007 | 1996 |
| Metric | BX | TMO |
|---|---|---|
| Price | $129.26 | $569.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 18 |
| Target Price | $156.53 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 3.4M | 2.1M |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.96% | 0.40% |
| EPS Growth | 6.91 | ★ 7.32 |
| EPS | 0.83 | ★ 4.43 |
| Revenue | $14,450,265,000.00 | ★ $20,918,000,000.00 |
| Revenue This Year | $12.40 | $6.55 |
| Revenue Next Year | $23.10 | $5.11 |
| P/E Ratio | $149.99 | ★ $129.19 |
| Revenue Growth | 9.22 | ★ 14.47 |
| 52 Week Low | $101.73 | $435.27 |
| 52 Week High | $190.09 | $643.99 |
| Indicator | BX | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 60.37 | 70.71 |
| Support Level | $125.27 | $555.69 |
| Resistance Level | $130.58 | $578.24 |
| Average True Range (ATR) | 3.88 | 13.88 |
| MACD | 0.30 | 2.62 |
| Stochastic Oscillator | 85.21 | 79.04 |
Blackstone is the world's largest alternative-asset manager with $1.304 trillion in total assets under management, including $937.6 billion in fee-earning assets under management, at the end of March 2026. The company operates with scale in each of its major product lines: private equity (27% of fee-earning AUM and 34% of base management fees), real estate/real assets (30% and 33%), credit and insurance (33% and 26%), and other alternatives (10% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).